UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2017 4:00 P.M.

Form:	S-3
CIK: 0001348911 Company Name: KalVista Pharmaceuticals, Inc. File Number: 333-217009